← Back to Clinical Trials
Recruiting NCT05525325

Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke

Trial Parameters

Condition Stroke Thrombectomy
Sponsor University Hospital Heidelberg
Study Type INTERVENTIONAL
Phase N/A
Enrollment 128
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-10-01
Completion 2026-10
Interventions
General Anesthesia

Brief Summary

Optimal anesthetic mode is not established for patients with vertebrobasilar stroke undergoing endovascular treatment. We want to investigate whether a procedural sedation mode approach is feasible compared to general anesthesia

Eligibility Criteria

Inclusion Criteria: 1. Decision for thrombectomy according to local protocol for acute recanalizing stroke treatment 2. Age 18 years or older, either sex 3. National Institutes of Health Stroke Scale (NIHSS) ≥ 4 4. Acute ischemic stroke in the posterior circulation with isolated or combined occlusion of vertebral artery (VA) and basilar artery (BA) 5. Informed consent by the patient him-/herself or his/her legal representative obtainable within 72 h of treatment (deferred consenting procedure) Exclusion Criteria: 1. Intracerebral hemorrhage 2. Coma on admission (Glasgow Coma Scale ≤ 8) 3. Severe respiratory instability, loss of airway protective reflexes or vomiting on admission, where primary intubation and general anesthesia is deemed necessary 4. Intubated state before randomization 5. Severe hemodynamic instability (e.g. due to decompensated cardiac insufficiency)

Related Trials